Tiziana Life Sciences Ltd. maintains its official corporate headquarters and registered office in London, United Kingdom. In addition to its corporate base in the UK, the clinical-stage biopharmaceutical enterprise operates executive management functions, investor relations, and collaborative research and development activities in the United States, closely partnering with premier academic medical centers and clinical trial sites located in Boston, Massachusetts, and other major biotechnology hubs.